Slingshot members are tracking this event:
Antares (ATRS) Files NDA with FDA for QuickShot Testosterone Subcutaneous Device
Slingshot Insights Explained
Dec 21, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords New Drug Application, Fda, Quickshot Testosterone, Subcutaneous, Device